Phase I study using weekly Taxol (T) and gemcitabine (G) in patients with advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
De Pas, T
De Braud, F
Sessa, C
Nole, F
Minchella, I
Catania, C
Goldhirsch, A
机构：
[1] EIO, Milano, Italy
[2] HS Giovanni, Bellinzona, Switzerland
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
375
引用
收藏
页码：98 / 99
页数：2
相关论文
共 50 条
  • [1] Phase I/II study of exisulind and gemcitabine in patients with recurrent advanced non-small cell lung cancer (NSCLC).
    Hoang, T
    Kim, K
    Merchant, J
    Traynor, AM
    Ahuja, HG
    Masters, GA
    McGovern, JD
    Oettel, KR
    Sanchez, FA
    Schiller, JH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 642S - 642S
  • [2] Phase II study of weekly gemcitabine in advanced non-small cell lung cancer
    Halme, M
    Jekunen, A
    Tamminen, K
    Mattson, K
    RESPIRATORY MEDICINE, 1997, 91 (07) : 423 - 426
  • [3] A phase II trial of thalidomide (T), irinotecan (I) and gemcitabine (G) in chemonaive patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Flora, DB
    Kleykamp, B
    Knapp, M
    Shukla, R
    Jazieh, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 680S - 680S
  • [4] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
  • [5] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
    Pirker, R
    Krajnik, G
    MohnStaudner, A
    Marhold, F
    Malayeri, R
    Zochbauer, S
    Kummer, F
    Greil, R
    Huber, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1139 - 1139
  • [6] Phase I study of gemcitabine (GEM) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC).
    Kawabata, S
    Oka, M
    Fukuda, M
    Kinoshita, A
    Fukuda, M
    Nagashima, S
    Nakamura, Y
    Nakano, H
    Soda, H
    Kohno, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 688S - 688S
  • [7] Gemcitabine (G), ifosfamide (I), vinorelbine (N) in advanced non-small cell lung cancer (NSCLC):: A phase II study.
    Morère, JF
    Pailler, MC
    Saintigny, P
    Bréchot, JM
    Morin, F
    Mir, D
    Martinez, A
    Breau, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 705S - 705S
  • [8] Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study
    Lippe, P
    Tummarello, D
    Monterubbianesi, MC
    Silva, RR
    Giuliodori, L
    Mari, D
    Santo, A
    Pasini, E
    Cetto, GL
    Rossi, D
    Porfiri, E
    Cascinu, S
    Cellerino, R
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 217 - 221
  • [9] Elderly patients with advanced non-small cell lung cancer - A phase II study with weekly cisplatin and gemcitabine
    Berardi, R
    Porfiri, E
    Scartozzi, M
    Lippe, P
    Silva, RR
    Nacciarriti, D
    Menichetti, ET
    Tummarello, D
    Carle, F
    Piga, A
    Cellerino, R
    ONCOLOGY, 2003, 65 (03) : 198 - 203
  • [10] A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC)
    Pino, Maria Simona
    Gamucci, Teresa
    Mansueto, Giovanni
    Trapasso, Tiziana
    Narducci, Filornena
    Giampaolo, Maria Anna
    Fariello, Anna Maria
    Sperduti, Isabella
    Ceribelli, Anna
    Cognetti, Francesco
    LUNG CANCER, 2008, 60 (03) : 381 - 386
12345